Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction
Nicolette M.S.K.J. Ernst, MD*,
Harry Suryapranata, MD, PhD, FACC*,
Kor Miedema, MD, PhD ,
Robbert J. Slingerland, MD, MSc, PhD ,
Jan Paul Ottervanger, MD, PhD*,
Jan C.A. Hoorntje, MD, PhD*,
A.T.Marcel Gosselink, MD, PhD*,
Jan-Henk E. Dambrink, MD, PhD*,
Menko-Jan de Boer, MD, PhD, FACC*,
Felix Zijlstra, MD, PhD, FACC and
Arnoud W.J. vant Hof, MD, PhD*,*
* Isala Klinieken, location Weezenlanden, Department of Cardiology, Zwolle, the Netherlands
Isala Klinieken, location Weezenlanden, Department of Clinical Chemistry, Zwolle, the Netherlands
Thorax Centre, Department of Cardiology, Groningen, the Netherlands
|